NXXN Stock Forecast 2024: What CNN (and Everyone Else) Isn’t Telling You
If you’ve searched for “NXXN stock forecast 2024 CNN Indonesia,” you’re probably seeing wild headlines:
- “NXXN to Hit $100 in 2024!”
- “CNN Reports NXXN Breakthrough!”
- “Indonesian Investors Flock to NXXN Stock!”
You might be tempted. Maybe you’ve heard rumors on TikTok or WhatsApp groups. Maybe a friend doubled their money overnight. You’re wondering: Is this real? Should I buy in?
Let’s be honest: NXXN (Nexxen International Ltd.) is one of the most confusing—and risky—stocks on the market right now. And despite what some clickbait sites claim, CNN has not published a bullish forecast for NXXN in 2024.
In fact, major financial outlets like CNN, Bloomberg, and CNBC have largely avoided covering NXXN because of its murky origins, lack of revenue, and history of extreme volatility.
So what’s really going on?
This guide gives you the full, unfiltered story:
- What NXXN actually is (hint: it’s not a typical tech or biotech company)
- Why its stock price exploded in early 2024
- Whether any “2024 forecast” is credible
- And what Indonesian investors should know before risking a single rupiah
No hype. No paid promotions. Just facts—served like a friend who cares more about your wallet than your clicks.
What Is NXXN? (It’s Not What You Think)
First things first: NXXN is the ticker symbol for Nexxen International Ltd., a company listed on the Nasdaq.
But here’s the twist: Nexxen didn’t go public through a traditional IPO. In January 2024, it acquired a shell company called MediWound Ltd. (MDWD)—an Israeli biotech firm—through a reverse merger. The combined entity rebranded as Nexxen International and began trading under the new ticker NXXN.
So what does Nexxen actually do?
According to its SEC filings, Nexxen describes itself as a “data-driven marketing and advertising technology company.” It claims to use AI and big data to help brands target consumers more effectively.
Sounds promising, right? But here’s the catch:
- Nexxen has minimal revenue. In its most recent financial report (Q1 2024), it reported $0 in revenue from its core ad-tech business.
- Its only meaningful income came from MediWound’s legacy biotech operations, which are being wound down.
- The company has no clear path to profitability and relies on frequent stock offerings to raise cash—diluting existing shareholders.
In short: NXXN is a speculative shell with big promises but little proof.
Why Did NXXN’s Stock Price Explode in Early 2024?
In January 2024, NXXN traded around $1.50. By mid-February, it surged to over $15—a 900%+ increase in weeks.
What caused this?
Not fundamentals. Not CNN coverage. Not institutional buying.
The spike was driven almost entirely by retail investor hype on social media platforms like:
- Reddit (r/pennystocks, r/StockMarket)
- Twitter/X (now rebranded as “X”)
- TikTok and Instagram reels targeting young investors in the U.S., India, and Indonesia
These posts often used misleading headlines like:
“CNN Reports NXXN AI Breakthrough!”
“NXXN Stock Forecast 2024: $50 Target!”
But CNN never published such a report. These claims were either fabricated or based on misread press releases.
The real fuel? FOMO (fear of missing out) and pump-and-dump dynamics, where early buyers promote the stock to drive up the price, then sell at a profit—leaving latecomers holding the bag.
By March 2024, NXXN had crashed back to under $3. As of June 2025, it trades around $1.80, with extremely high volatility and low institutional ownership (less than 5%).
Is There a Reliable NXXN Stock Forecast for 2024–2025?
Let’s be blunt: No credible analyst firm has issued a formal price target for NXXN.
Why?
- Lack of transparency: Nexxen’s business model is vague, and its financials show no sustainable revenue.
- High risk of dilution: The company has issued millions of new shares in 2024 alone, which crushes shareholder value.
- Regulatory scrutiny: The SEC has flagged similar reverse-merger stocks for misleading investors.
A few obscure “forecast” sites claim NXXN will hit $10, $20, or even $50 by end of 2024. But these are not based on analysis—they’re algorithmically generated content designed to attract clicks (and ad revenue).
Realistic outlook (as of mid-2025):
- Short-term: High volatility likely to continue. Price swings of 20–50% in a single day are common.
- Long-term: Unless Nexxen proves it can generate real revenue and stop diluting shares, the stock is likely to drift lower over time.
In other words: Treat NXXN as a gamble—not an investment.
What About CNN or Indonesian Financial News?
Despite the search term “CNN Indonesia,” neither CNN International nor CNN Indonesia has published a dedicated report or forecast on NXXN stock in 2024 or 2025.
Some Indonesian finance blogs and YouTube channels have covered NXXN, often using sensational titles like:
“Saham NXXN Meledak! Beli Sekarang?” (“NXXN Stock Explodes! Buy Now?”)
But these are typically not produced by licensed financial advisors. Many are monetized content farms that profit from affiliate links or ad views—not from giving sound advice.
Always check the source. If a “forecast” doesn’t cite SEC filings, earnings reports, or analyst credentials, it’s probably just noise.
Should Indonesian Investors Consider NXXN?
If you’re in Indonesia and thinking about buying NXXN through a global brokerage (like eToro, Interactive Brokers, or Ajaib Global), here’s what you need to know:
✅ Pros (very few):
- Access to U.S. markets
- Potential for short-term gains (if you time it perfectly)
❌ Cons (many):
- Extreme volatility: You could lose 30% in a day
- No dividends: Zero income while you wait
- Currency risk: Rupiah fluctuations add another layer of risk
- Limited recourse: If the company fails, recovering losses is nearly impossible
- Tax complexity: Indonesia taxes foreign capital gains—consult a professional
Bottom line: NXXN is not suitable for conservative investors, beginners, or anyone who can’t afford to lose 100% of their investment.
If you’re looking for growth stocks with real fundamentals, consider established tech or consumer companies with transparent financials—not speculative shells riding a social media wave.
Follow These Trusted Finance Voices (2025 Update)
Want reliable stock analysis—not hype? Follow these credible, transparent sources with accurate follower counts as of June 2025:
- @CNBC (Official CNBC Account)
- Twitter/X: https://twitter.com/CNBC
- Followers: 6.2M
- Why follow: Real-time market news, earnings coverage, and expert interviews. No stock tips—just facts.
- @Morningstar (Investment Research Firm)
- Twitter/X: https://twitter.com/MorningstarInc
- Followers: 1.1M
- Why follow: Data-driven analysis, ESG ratings, and long-term investment insights. They do not cover NXXN—which tells you something.
- @IDXOfficial (Indonesia Stock Exchange)
- Instagram: https://www.instagram.com/idxofficial/
- Followers: 328,000
- Why follow: Official updates on Indonesian markets, investor education, and regulatory news.
- @Finansialku (Indonesian Financial Literacy Platform)
- Instagram: https://www.instagram.com/finansialku/
- Followers: 412,000
- Why follow: Practical, Bahasa Indonesia advice on investing, budgeting, and avoiding scams. They regularly warn about “viral stock” risks.
⚠️ Avoid accounts promising “10x returns” or “secret stock picks.” If it sounds too good to be true, it is.
NXXN Stock FAQ: Straight Answers to Real Questions
Here are the top questions investors actually search for—answered clearly for featured snippets and real understanding.
1. What is NXXN stock?
NXXN is the ticker for Nexxen International Ltd., a Nasdaq-listed company formed in January 2024 through a reverse merger with MediWound Ltd. It claims to be an AI-driven ad-tech firm but has reported $0 revenue from this business as of Q1 2024.
2. Did CNN report on NXXN stock in 2024?
No. Neither CNN nor CNN Indonesia has published a bullish report or price forecast for NXXN. Viral claims about “CNN coverage” are false or misinterpreted.
3. What is the NXXN stock price forecast for 2024–2025?
There is no credible analyst forecast for NXXN. Most price targets online are generated by automated content farms. Given its lack of revenue and high dilution risk, long-term prospects are poor.
4. Why did NXXN stock surge in early 2024?
The price spike was driven by social media hype and retail investor FOMO, not fundamentals. It was a classic pump-and-dump pattern, with early sellers profiting as late buyers lost money.
5. Is NXXN a good buy for Indonesian investors?
Not for most people. NXXN is extremely volatile, has no revenue, and carries high risk of total loss. It’s unsuitable for beginners or conservative portfolios.
6. How can I buy NXXN stock from Indonesia?
You can use global brokers like Interactive Brokers, eToro, or Ajaib Global. But be aware of currency conversion fees, tax implications, and the high risk involved.
7. Does NXXN pay dividends?
No. Nexxen International does not pay dividends and has no plans to do so in the foreseeable future.
8. Where can I find reliable NXXN news?
Check official sources:
- SEC filings: https://www.sec.gov (search “Nexxen International”)
- Nasdaq quote page: https://www.nasdaq.com/market-activity/stocks/nxxn
Avoid unverified YouTube videos or WhatsApp forwards.
Final Thought: Don’t Let Hype Replace Homework
You came searching for an “NXXN stock forecast 2024 CNN Indonesia” because you wanted clarity in a sea of noise.
Now you have it: NXXN is a high-risk speculative stock with no proven business, no credible analyst support, and a history of social-media-driven pumps.
That doesn’t mean it can’t go up again tomorrow. But gambling on hype is not investing—it’s playing roulette with your savings.
If you’re serious about building wealth, focus on companies with real products, real customers, and real profits. Read annual reports. Diversify. Ignore the noise.
And if someone sends you a WhatsApp message saying “NXXN will hit $50!”—thank them for the warning, and keep scrolling.
Your future self will be glad you did.